S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7120 +0.15%
CLOSED · 21:35 ET
Market ClerkRecap
Wed Oct 21 · markets closed2 signals today78 insider buys this week · $240.8MCIRO short report next: Oct 31The week ahead

APTX

Apotex Health Corp.
TSX · HEALTH CARE · LIFE SCIENCES
33.23
+0.73 +2.25%
CAD · Oct 21, 07:43 p.m. ET

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

One year, everything drawn on

92 SESSIONS · DAILY CLOSES
41363126JUN 2026JUL
Insider buyInsider sellHOVER A MARKER FOR THE FILING
THE WORK ORDER · 2026-10-21
Shorts (latest report): 1.5M short · +319K last period
Street (tracked calls): 1 scored · avg −12.3 pts vs index
Every line of the math
7FLAG

Insider activity

No open-market insider filings on APTX in the imported SEDI data.

Short interest

HISTORY
ReportShares shortChange
2026-09-301.5M+319K
2026-09-151.2M+200K
2026-08-311M+85K
2026-08-15927K+252K
2026-07-31676K+452K
2026-07-15224K−98K

Calls on APTX

SCORED VS INDEX
WhoThe callCalledReturnVs index
Brian MaddenPicked recently-IPO'd Apotex Health, projecting roughly 20% Canadian market share in generic semaglutide as Canada's largest pharma manufacturer.logged from a dated source2026-08-07 · $37.38−11.1%−10.9 behind
Watch APTX. Know when insiders buy.
One email the day a filing lands. Free.